Instruction for use: Albumin

Dosage form: Solution for infusions

Active substance: Albuminum humanum

ATX

B05AA01 Albumin

Pharmacological groups

Substitutes for plasma and other blood components

Means for enteral and parenteral nutrition

The nosological classification (ICD-10)

K25 Stomach ulcer: Helicobacter pylori; Pain syndrome with gastric ulcer; Pain syndrome with peptic ulcer of stomach and duodenum; Inflammation of the gastric mucosa; Inflammation of the mucosa of the gastrointestinal tract; Benign ulcer of the stomach; Disease of the stomach and duodenum, associated with Helicobacter pylori; Exacerbation of gastroduodenitis against ulcer disease; Exacerbation of peptic ulcer; Exacerbation of gastric ulcer; Organic GI disease; Peptic ulcer of the stomach and duodenum; Postoperative Stomach Ulcer; Recovering ulcers; Symptomatic Stomach Ulcers; Chronic inflammatory disease of the upper gastrointestinal tract associated with Helicobacter pylori; Helicobacter pylori eradication; Erosive-ulcerative lesions of the stomach; Erosive lesions of the stomach; Erosion of the gastric mucosa; Peptic Ulcer; Stomach ulcer; Stomach ulcer; Ulcerative lesions of the stomach; Symptomatic ulcers of the stomach and duodenum

K26 Ulcer of duodenum: Pain syndrome with duodenal ulcer; Pain syndrome with peptic ulcer of stomach and duodenum; Disease of the stomach and duodenum, associated with Helicobacter pylori; Exacerbation of peptic ulcer; Exacerbation of duodenal ulcer; Peptic ulcer of the stomach and duodenum; Recurrence of duodenal ulcer; Symptomatic ulcers of the stomach and duodenum; Helicobacter pylori eradication; Erosive-ulcerative lesions of the duodenum; Erosion-ulcerative duodenal lesions associated with Helicobacter pylori; Erosive lesions of the duodenum; Peptic ulcer disease of the duodenum; Ulcerative duodenal lesions

R57 Shock, not elsewhere classified: Obstructive shock

T30 Thermal and chemical burns of unspecified site: Pain syndrome with burns; Pain in burns; Pain with burns; Sluggishly healing post-burn wounds; Deep burns with a wet scab; Deep burns with abundant compartments; Deep burn; Laser burn; Burn; Burn of rectum and perineum; Burn with mild exudation; Burn disease; Burn injury; Superficial burn; Superficial burn of I and II degree; Superficial skin burns; After-burn trophic ulcer and wound; Post-burn complication; Loss of fluid in burns; Sepsis burn; Thermal burns; Thermal skin lesions; Thermal burn; Trophic after-burn ulcers; Chemical burn; Surgical burn

T79.4 Traumatic shock: Haemorrhagic shock; Crash Syndrome; Posthemorrhagic shock; Postoperative shock; Post-traumatic shock; Post-traumatic shock; Traumatic shock; Syndrome of hemorrhagic shock and encephalopathy

T81.1 Shock during or after the procedure, not elsewhere classified: Operating shock; Postoperative shock; Operational shock

Composition and release form

10% solution for infusions in 100 ml vials.

Characteristic

A solution of the human plasma protein. Transparent, viscous liquid of amber color.

Pharmachologic effect

Mode of action - Anabolic, replenishing protein deficiency.

Supports oncotic blood pressure, increases BCC, increases blood pressure, promotes the passage of tissue fluid in the bloodstream, provides the body with proteins.

Indications for the preparation Albumin

Traumatic and operational shock, burns accompanied by dehydration, hypoproteinemia and hypoalbuminemia, liver cirrhosis, gastrointestinal lesions (peptic ulcer, tumors, gastrointestinal anastomosis), acute pancreatitis, cerebral edema, prolonged suppuration, dystrophy, nephropathic syndrome.

Contraindications

Thrombosis, hypertension, internal bleeding.

Dosing and Administration

IV, drip, at a rate of 3 ml (50-60 drops) per minute - for 100-500 ml.

Storage conditions of the drug Albumin

At a temperature of 2-10 ° C.

Keep out of the reach of children.

The shelf life of the drug Albumin

5 years.

Do not use beyond the expiration date printed on the package.